Webinar
Masterclass Live! How We Evaluate a Venture Deal
Watch an on-demand presentation hosted by Alumni Ventures’ Provo Ventures. In this session, you’ll discover how to evaluate a deal, walk through the process our investment team uses to invest in promising startups and learn how you, too, can invest in startups like this through Alumni Ventures’ Provo Ventures.
See video policy below.
During the session, we will discuss:
- HomeDetermining if a prospective deal fits in with your overall diversification goals
- HomeUnderstanding the time horizon of venture investments
- HomePerforming due diligence and reviewing the typical types of materials available in a deal
- HomeWeighing some of the challenges, key risks, and how to factor into the ultimate decision
- HomeTracking companies after investment and the purpose of portfolio monitoring
- HomeMore details about Provo Ventures
About Alumni Ventures
Top 20 VC Investors in North America (2024)
#1 Most Active Venture Firm in the U.S. (2023)
#1 Most Active Venture Firm in the U.S. (2022)
World's Most Innovative Companies (2022)
Note: You must be accredited to invest in venture capital. Important disclosure information can be found at av-funds.com/disclosures.
About your presenter
Overview
Matt Caspari invests in mission-driven founders building the next generation of iconic companies—entrepreneurs tackling the world’s hardest, highest-stakes problems. He backs breakthrough technologies with the potential to redefine critical industries, unlock new markets, and create a more sustainable, secure future.
Before Alumni Ventures, Matt was a two-time venture-backed founder/CEO and a leader of the innovation team at Nike. He founded Aurora Biofuels, a deep-tech venture that grew to 100+ employees and secured more than $100 million in funding before its acquisition by Reliance Industries. Earlier, he advised life science multinationals at Cambridge Pharma Consultancy (acquired by IMS Health) and gained experience on Bloomberg’s M&A team. Matt holds a BS in Biochemistry from Georgetown University and an MBA with a Certificate in Entrepreneurship from UC Berkeley.
Funds actively worked on
Investment Area of Focus
His investment lens favors bold solutions to global challenges and durable advantages rooted in technology and aligned with long-term megatrends. This translates to surgical robots powered by physical AI, next-generation energy systems, space-based infrastructure, longevity therapeutics, and more. The through-line is the potential for extraordinary value creation at the intersection of deep science and global need.
Representative investments Matt has led for Alumni Ventures include Andromeda Surgical and Cytronic (Physical AI); Arda Therapeutics and Cambrian Biopharma (Technologies for the Human Body); Max Space and Orbital Operations (Space Infrastructure); and Fortera and Mainspring Energy (The New Energy Stack). Alumni Ventures’ Deep Tech portfolio also includes companies such as Axiom Space, Ayar Labs, Cohere, Frore Systems, Groq, Hawkeye360, Hayden AI, Lambda, Radiant, and Rigetti (Nasdaq: RGTI).